Litcius/Paper detail

Association of change in alcohol consumption with cardiovascular disease and mortality among initial nondrinkers

Jun Young Chang, Seulggie Choi, Sang Min Park

2020Scientific Reports14 citationsDOIOpen Access PDF

Abstract

There is a paucity of studies on the influence of alcohol intake among non-drinkers. We evaluated the association between an increase in alcohol consumption and primary prevention of major adverse cardiovascular events (MACE) among non-drinkers. Data collected by the National Health Insurance Service in the Korea between 2007 and 2013 were analysed. A total of 112,403 subjects were included and followed up from 1 January 2011 to 31 December 2013. Increases in alcohol consumption, measured as glasses per day, at the second medical check-up, were categorized into maintenance of nondrinking (0), > 0- ≤ 1, > 1- ≤ 2, > 2- ≤ 4, and > 4. Hazard ratios (HRs) for MACE and all-cause mortality on increase in alcohol consumption were calculated. Compared to that in non-drinkers at the second check-up, the risk of MACE significantly decreased among the subjects with an increase in alcohol consumption to ≤ 1 glass per day (HR 0.79, 95% CI 0.68-0.92). However, a light increase in alcohol consumption did not reduce the risk of stroke or all-cause mortality (stroke, HR 0.83, 95% CI 0.68-1.02; all-cause mortality, HR 0.89, 95% CI 0.73-1.09). Compared to continual non-drinkers, those who drank > 2 glass per day had higher risk for death due to external causes (aHR 2.06, 95% CI 1.09-3.90). The beneficial effect of light increments in alcohol consumption on the occurrence of MACE may have resulted from the inappropriate inclusion of sick quitters, who maintained a nondrinking status, in the reference group.

Topics & Concepts

MaceMedicineHazard ratioAlcohol consumptionAlcoholStroke (engine)Proportional hazards modelInternal medicineConfidence intervalMyocardial infarctionBiologyConventional PCIBiochemistryEngineeringMechanical engineeringAlcohol Consumption and Health EffectsSubstance Abuse Treatment and OutcomesDiabetes, Cardiovascular Risks, and Lipoproteins